International Women’s Day: “Everyone benefits from raising awareness”
Women and Parkinson's
Author: Sarah McGrathPublished: 3 March 2022
Prep: Cook: Serves:
Around three million women worldwide are living with Parkinson’s – but their specific needs and experiences are often neglected. Ahead of International Women’s Day 2022, we look back at our #WomenandParkinsons campaign – where interviewees share how the condition has impacted their lives
We launched the #WomenAndParkinsons campaign in 2019 to highlight the knowledge gap around how Parkinson’s affects women. Investigating the topic revealed some shocking insights. Women experience a more rapid disease progression, a lower survival rate, are less likely to be monitored by a movement disorders specialist – and are less likely than men to undergo complex treatments like deep brain stimulation.
At the start of the campaign, Russell Patten, director general of Parkinson’s Europe, said: “This campaign is necessary if women living with Parkinson’s are to receive what they, and everyone living with Parkinson’s, deserve: an appropriate diagnosis, improved treatment options and a better quality of life.”
More than two years later, we’ve been lucky to speak to women in the community about a variety of subjects including diagnosis, menopause, medication and research.
Ireland-based dietician Richelle Flanagan hid her Parkinson’s diagnosis for two years, for “fear of judgment”. But after meeting other people with the condition and visiting the World Parkinson Congress in 2019, she felt motivated to share her story.
Making people aware of the impact the condition has on women was particularly important to Richelle. So far she has set up a survey about hormones and women’s Parkinson’s symptoms, and co-founded the Women’s Parkinson’s Project to help advocate for better treatment and research for women living with the condition. After all, Richelle says, “everyone benefits from raising awareness”.
Series one of Parkinson’s Life podcast saw campaigners Sharon Krischer, Omotola Thomas and Mariette Robijn get together, discussing topics that ranged from the stereotype that people with Parkinson’s tend to be “old, grey, dusty men”, to the discovery that symptoms “will be worse during your period”. The group noted that being better informed about Parkinson’s during their diagnosis “would have made a difference” to their experiences of the condition.
When Cathy Molohan was first diagnosed with Parkinson’s, she was “determined” not to let the condition stop her role co-running the communications company EnglishBusiness.
Although Parkinson’s symptoms meant parts of the work became “exhausting”, Cathy was grateful to her “amazing” colleagues and clients for their support. “It was a hard balancing act to look after myself and my business commitments at the same time,” she explains.
Cathy eventually decided to leave her job to focus on spending time with her family. “It’s essential to create a workplace where chronic illness is not a taboo,” she says. “I think many women try and be everything and do everything – Parkinson’s just doesn’t allow that. Or at least, it forces you to choose what and how much you do.”
At the age of 37, a Parkinson’s diagnosis left María Martinez* with a “monumental” identity crisis. She initially struggled, as she left her job as a journalist and grappled with impulsive behaviours linked to her Parkinson’s medication. But after having psychological therapy at a specialised centre for women, María began to accept the condition and put her life in place.
“Women have to learn to be their own highest priority in life,” she says. “We have to learn to say ‘me first’, we have to learn to say ‘no’ on our own, without the consent of the group. We have to learn to be impervious to social judgment – even more so if health is at stake.”
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Our campaign shares the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’
Parkinson’s Life’s #WomenAndParkinsons campaign – a series highlighti
3 days ago
Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease
Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…
Machine learning may help predict risk of freezing of gait in Parkinson’s disease
Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.
Long-term exposure to air pollution could impact Parkinson’s disease mortality risk
New research has suggested that long-term exposure to air pollutants could increase the risk of death from Parkinson’s. A team of European researchers conducted the study, published in the journal ‘Environment International’, as part of the Effects of Low-Level Air Pollution: A Study in Europe (ELAPSE) project – a Europe-wide initiative looking at the effects of low air pollution levels on people’s health. The researchers used ELAPSE’s datasets to analyse figures for over 200,000 adults from six European countries. They also looked at air pollution models, estimating the concentrations of air pollutants in these countries to explore the link between pollution exposure and deaths from Parkinson’s. The results suggest that long-term exposure to PM2.5 particles at high levels was associated with a 25% higher risk of death from the condition, and the authors of the study added that the research “adds strong evidence in support of an association between air…